D2V Clinical is the early oncology, hematology and rare disease development partner for biopharmaceutical sponsors in the US and China. We are a full-service global CRO offering world-class clinical development insight and end-to-end capabilities. With 20+ years of leadership in clinical research and investor value creation, we bring the depth of knowledge required to value your asset, connect your studies to the right patient populations and sites, and conduct an efficient and seamless study.